Policy Notices

• Special Emphasis Notice (SEN): AHRQ Announces Interest in Supporting Primary Care Research Career Development Awards
  (NOT-HS-22-002)
  Agency for Healthcare Research and Quality
  

• Notice of Clarification of Institutional Responsibilities Regarding NIH Grant to Protocol Congruence Review
  (NOT-OD-22-005)
  Office of the Director, NIH
  

• NIH Operates Under a Continuing Resolution
  (NOT-OD-22-009)
  National Institutes of Health
  

General Notices

• Notice of NCI's Participation in PAR-20-070, "Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional)"
  (NOT-CA-22-002)
  National Cancer Institute
  

• Notice of High Priority Research Areas for NIDA T32 Training Grants
  (NOT-DA-21-087)
  National Institute on Drug Abuse
  

• RESCINDED - Notice of Invitation for Applicants to NIDCD PAR-21-063 and PAR-21-064 to Consult with the NCATS Clinical and Translational Science Award (CTSA) Trial Innovation Network (TIN) Prior to Submission
  (NOT-DC-21-006)
  National Institute on Deafness and Other Communication Disorders
  National Center for Advancing Translational Sciences
  

• RESCINDED - Notice of Informational Webinar for PAR-21-063 and PAR-21-064: Planning to Consult with the Clinical and Translational Science Award (CTSA) Trial Innovation Network (TIN)
  (NOT-DC-22-002)
  National Institute on Deafness and Other Communication Disorders
  

• RESCINDED - Modifications to the NIMH Special Council Review Procedures
  (NOT-MH-22-030)
  National Institute of Mental Health
  

• Notice of Clarification of Offeror Responsibilities Regarding Contract to Protocol Congruence Review
  (NOT-OD-22-006)
  Office of the Director, NIH
  

• Flexibility Available to Lasker Clinical Research Scholars Affected by COVID-19
  (NOT-OD-22-007)
  National Institutes of Health
  

• The National Institutes of Health (NIH) Common Fund Announces Listening Sessions to Inform Health Disparities Research and Advance Health Equity
  (NOT-RM-22-002)
  Office of Strategic Coordination (Common Fund)
  

• Request for Information (RFI): Soliciting Input on Priorities and Progress in Alzheimers Disease-Related Dementias Research
  (NOT-NS-22-032)
  National Institute of Neurological Disorders and Stroke
  

Notice of Changes to Funding Opportunities

• Notice of Early Expiration of NOT-AI-21-067, Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes"
  (NOT-AI-21-081)
  National Institute of Allergy and Infectious Diseases
  National Heart, Lung, and Blood Institute
  

• Notice of Clarification of Research Objectives and Scope in RFA-AI-21-060, SUNBEAM - Analysis and Bioinformatics Center (ABC) (UM1 Clinical Trial Not Allowed)
  (NOT-AI-22-008)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Change to RFA-DA-22-033, "Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed)"
  (NOT-DA-21-089)
  National Institute on Drug Abuse
  

• Notice of Participation of the National Institute of Dental and Craniofacial Research (NIDCR) in PAR-21-287 Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional)
  (NOT-DE-21-016)
  National Institute of Dental and Craniofacial Research
  

• Notice of NIEHS Participation on PAR-22-048 "Clinical Relevance of the Linkage between Environmental Toxicant Exposures and Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)"
  (NOT-ES-22-002)
  National Institute of Environmental Health Sciences
  

• Notice of NICHD Participation in PAR-21-213, "Urgent Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed)"
  (NOT-HD-21-046)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for the NIH Blueprint Training in Computational Neuroscience (T90/R90)
  (NOT-DA-21-085)
  National Institute on Drug Abuse
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Behavioral and Social Sciences Research
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Implementation Research for Chronic Disease Prevention Across the Lifespan (R01 Clinical Trial Optional)
  (NOT-TW-21-008)
  John E. Fogarty International Center
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Leveraging Microbial Exposure for Improving Mouse Models of Human Immunity
  (NOT-AI-21-072)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes
  (NOT-AI-21-080)
  National Institute of Allergy and Infectious Diseases
  National Heart, Lung, and Blood Institute
  

• Notice of Special Interest (NOSI): NIDDK T32 Medical Student Research Training Administrative Supplement
  (NOT-DK-21-015)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

Funding Opportunities

• Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01)
  (PA-22-047)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): October 30, 2026
  
  

• Large Health Services Research Demonstration and Dissemination Projects for Combating Antibiotic-Resistant Bacteria (CARB)(R18)
  (PA-22-048)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): October 30, 2026
  
  

• Clinical Research Education and Career Development (CRECD) Program (R25-Independent Clinical Trial Not Allowed)
  (PAR-21-347)
  National Institute on Minority Health and Health Disparities
  National Institute of Dental and Craniofacial Research
  National Institute of Nursing Research
  Application Receipt Date(s): December 15th, 2021
  
  

• Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
  (PAR-22-049)
  National Cancer Institute
  Application Receipt Date(s): September 13, 2024
  
  

• CVM Vet-LIRN Veterinary Diagnostic Laboratory Program (U18) Clinical Trials Not Allowed
  (PAR-22-063)
  Food and Drug Administration
  Application Receipt Date(s): February 10, 2022, February 10, 2023, February 9, 2024, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
  
  

• Identification and Characterization of Persistence Mechanisms of Select Protozoan Pathogens (R01 Clinical Trial Not Allowed)
  (RFA-AI-21-075)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): February 08, 2022
  
  

• A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Optional)
  (RFA-CA-21-063)
  National Cancer Institute
  Application Receipt Date(s): December 10, 2021
  
  

• Expanding Differentiated Care Approaches for Adolescents Living with HIV (R01 Clinical Trial Optional)
  (RFA-MH-22-105)
  National Institute of Mental Health
  Application Receipt Date(s): January 06, 2022
  
  

• Expanding Differentiated Care Approaches for Adolescents Living with HIV (R34 Clinical Trial Optional)
  (RFA-MH-22-106)
  National Institute of Mental Health
  Application Receipt Date(s): January 06, 2022
  
  

• Enhanced Interpersonal Focused Strategies for Suicide Prevention Interventions (R34 Clinical Trial Required)
  (RFA-MH-22-125)
  National Institute of Mental Health
  Application Receipt Date(s): February 18, 2022